New Warnings To Be Placed On Drugs Used During Pregnancy, FDA Alerts

New warnings will be placed on drugs used during pregnancy

New warnings are to be placed on many medications potentially used by pregnant women and the potential dangers on their unborn children, the FDA reports.

Many drugs used to treat bipolar disorder and schizophrenia in women, such as Zyprexa, Risperdal, and Abilify, are going to notice more strict requirements with the warning labels.

While most health professionals are aware of the dangers, and this information is typically passed to women who will be taking the medications, the Food and Drug Administration explains that the information needs to be readily available at all times on the medication bottles.

Nearly 70 reports of infant health problems were reported to the FDA, and they were thought to be caused by women who medicated with these drugs late in their pregnancies.

The potential health symptoms for infants include tremors, sleepiness, and lack of normal muscle movement.

While the drugs were shown to cause potential health hazards for infants, women were alerted to not stop medicating instantly if they found out to be pregnant. Health officials explain that sudden stoppage of medication may cause other severe health risks for the unborn child and the woman.

Experts recommend consulting with a doctor about any questions regarding medications or the potential dangers of medications during pregnancy.